#United States #New York #New York City #Oral Surgery #MAX Surgical

MAX Surgical Specialty Management Expands into New York City

MAX Surgical Specialty Management (MAX), a leading platform dedicated to oral and maxillofacial surgery (OMS) in the Northeast, has made a significant leap by establishing a partnership with New York Oral Maxillofacial Surgery and Dental Implant Center. This collaboration marks not only a strategic expansion into the vibrant New York City healthcare market but also underscores MAX’s commitment to combining surgical mastery with operational excellence.

A New Era in Oral Surgery

This partnership is positioned as a landmark development within the highly competitive New York City healthcare landscape. The collaboration highlights MAX’s aspiration to create a model that elevates the standard of surgical care without compromising the autonomy of its surgeons.

Jason M. Auerbach, DDS, the co-founder and Co-CEO of MAX, emphasized the importance of this partnership, stating, "This isn't just another partnership. This is the partnership." By collaborating with two of the city’s most esteemed oral surgeons, the firm signals a serious intent to innovate and elevate patient care while providing a supportive platform for clinical leaders.

The Surgeons Behind the Partnership

The partnership brings two highly respected practitioners into MAX’s growing network: Dr. David Koslovsky and Dr. Mark Stein. Both are recognized not just for their clinical expertise but also for their dedication to improving patient experiences through innovative practices and cutting-edge technologies. Dr. Koslovsky, known for his compassionate approach and technical skill in complex cases, offers a range of services from corrective jaw surgery to facial trauma management. Conversely, Dr. Stein’s dual degree in dental and medical fields has allowed him to focus on challenging oral and maxillofacial surgery, specifically in bone regeneration and dental implant surgery.

"The best surgeons want a partner—not a parent company," noted Mark Censoprano, Co-CEO of MAX. This partnership serves as a testament to that philosophy. The support offered by MAX allows surgeons like Drs. Koslovsky and Stein to push the boundaries of surgical care without worrying about operational burdens.

Unmatched Support and Innovation

Founded in 2022, MAX Surgical Specialty Management aims to redefine the practice of oral and maxillofacial surgery by offering its partners robust operational support and advanced technology, thus helping them to deliver exceptional patient care. With the recent expansion into New York City, MAX is now extending its geographic reach to five states and experiencing substantial growth in production, collections, and patient volume.

By focusing on camaraderie and performance, MAX has witnessed nearly a 60% increase in its surgeon network since 2023. The firm prides itself on having a model that is surgeon-led, allowing its partners to receive the backing necessary for growth while maintaining their identity and clinical autonomy.

The Future Looks Bright

Both Dr. Koslovsky and Dr. Stein bring a wealth of experience to the MAX network with their proven track records and dedication to patient care. Dr. Koslovsky has spent over 15 years developing his expertise in complex oral conditions, while Dr. Stein has over 25 years of experience in oral surgery, further enhancing the high caliber of surgeons that MAX associates with.

The idea behind this partnership is not merely to expand geography but to enrich the clinical landscape with a focus on innovation, patient-centered care, and the continuous pursuit of clinical excellence. As Dr. Stein mentioned, "We've gotten here by relentlessly pursuing clinical excellence and innovation. MAX values our hard-earned reputation and safeguards our clinical autonomy."

MAX Surgical Specialty Management's entry into New York City is not just a physical expansion; it symbolizes a pivotal moment for the oral surgery sector, paving the way for new standards of care and operational success within the industry. It is a significant step that brings together expertise and groundbreaking practices to redefine patient experiences and surgical outcomes.